We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

161 hedge funds and large institutions have $176M invested in Heron Therapeutics in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 51 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,109% more call options, than puts

Call options by funds: $4.61M | Put options by funds: $64K

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4.75% less ownership

Funds ownership: 80.32% → 75.57% (-4.8%)

7% less funds holding

Funds holding: 173 → 161 (-12)

18% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 51

26% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 35

27% less capital invested

Capital invested by funds: $242M → $176M (-$66.6M)

Holders
161
Holders Change
-12
Holders Change %
-6.94%
% of All Funds
2.12%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
42
Reduced
51
Closed
35
Calls
$4.61M
Puts
$64K
Net Calls
+$4.55M
Net Calls Change
+$4.47M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.99M
2
Morgan Stanley
Morgan Stanley
New York
+$1.66M
3
SCM
Stonepine Capital Management
Oregon
+$1.13M
4
CPC
Congress Park Capital
New York
+$774K
5
QOP
Quinn Opportunity Partners
Virginia
+$616K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$2.58M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2.28M
3
Goldman Sachs
Goldman Sachs
New York
-$1.71M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.33M
5
N
Nuveen
North Carolina
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
51
Anfield Capital Management
California
$182K +$10.2K +6,264 +6%
Principal Financial Group
52
Principal Financial Group
Iowa
$174K +$17.7K +10,909 +11%
IWC
53
Integrated Wealth Concepts
Massachusetts
$170K +$101K +62,305 +128%
CPA
54
Capital Planning Advisors
California
$163K +$50.3K +31,003 +41%
Verition Fund Management
55
Verition Fund Management
Connecticut
$157K -$8.54K -5,272 -5%
BFO
56
Biltmore Family Office
North Carolina
$155K +$164K +101,467 New
Citigroup
57
Citigroup
New York
$139K +$8.15K +5,031 +6%
SC
58
Searle & Co
Connecticut
$132K – – –
Wells Fargo
59
Wells Fargo
California
$114K +$22K +13,568 +22%
MIM
60
MetLife Investment Management
New Jersey
$111K +$1.03K +635 +0.9%
SG Americas Securities
61
SG Americas Securities
New York
$110K +$1.14K +706 +1%
Invesco
62
Invesco
Georgia
$109K +$32K +19,738 +38%
MI
63
Motiv8 Investments
Florida
$106K -$13.6K -8,401 -11%
Commonwealth Equity Services
64
Commonwealth Equity Services
Massachusetts
$104K +$7.38K +4,550 +7%
Los Angeles Capital Management
65
Los Angeles Capital Management
California
$104K -$248K -153,181 -69%
Mirae Asset Global ETFs Holdings
66
Mirae Asset Global ETFs Holdings
Hong Kong
$103K +$4.68K +2,888 +4%
Deutsche Bank
67
Deutsche Bank
Germany
$91.5K – – –
CF
68
Corebridge Financial
Texas
$89.3K -$7.14K -4,406 -7%
Susquehanna International Group
69
Susquehanna International Group
Pennsylvania
$89.2K -$112K -68,806 -54%
IIM
70
INTECH Investment Management
Florida
$89.1K +$36.1K +22,254 +62%
LPL Financial
71
LPL Financial
California
$88.9K -$12.3K -7,559 -12%
AC
72
Aristides Capital
Kentucky
$80.9K +$85.7K +52,849 New
CSA
73
Cornerstone Select Advisors
Missouri
$77.7K +$82.3K +50,755 New
AWA
74
Arkadios Wealth Advisors
Georgia
$76.5K +$81K +50,000 New
Jane Street
75
Jane Street
New York
$73.2K -$461K -284,299 -86%
1 2
3
4 5

HRTX Hedge Fund Activity: Q4 2024 in Review

161 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2024, worth a combined $176M — down 27% from $242M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of HRTX and 26 opened new positions — a net loss of 9 holders — while 51 trimmed existing stakes and 42 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $4.99M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.58M sold.

  • 161 institutional investors held Heron Therapeutics (HRTX) as of Q4 2024, down from 173 in Q3 2024.
  • Funds reported $176M of Heron Therapeutics stock for Q4 2024, down 27% quarter-over-quarter.
  • 26 funds opened new Heron Therapeutics positions in Q4 2024 and 35 closed out, a net change of -9 holders.
  • The largest Heron Therapeutics buyer in Q4 2024 was Point72 Asset Management, an estimated $4.99M added.
  • The largest Heron Therapeutics seller in Q4 2024 was Citadel Advisors, an estimated $2.58M sold.

Based on aggregated 13F filings for Q4 2024.